The Chang Stem Cell Engineering Facility genetically modifies embryonic stem (ES) cells and induced pluripotent stem (iPS) cell lines. Genetically modified ES and iPS cell lines derived from disease-specific animal models and patients provide an opportunity to investigate the mechanisms of disease and to further develop new treatments for clinical therapy.
Services include: genome editing, iPS cell derivation, and ES cell derivation.
Health Sciences Campus
Eli and Edythe Broad CIRM Center
1425 San Pablo Street, BCC 205
Los Angeles, CA 90033